Siemens Denied Patent Rehearing In Enzo DNA Spat
The denial, announced Monday by Enzo, finalizes the board's previous ruling and will give Enzo a full 17-year patent for the invention. Siemens, however, can appeal the ruling to federal court.
"This technology is the basis for a number of significant products in clinical diagnostics and...
To view the full article, register now.